UCI statement on Denise Betsema

Apr 5, 2019, 16:59 PM

The Union Cycliste Internationale (UCI) announces that the Dutch rider Denise Betsema was notified of an Adverse Analytical Finding (AAF) of Endogenous Anabolic Androgenic Steroid(s) administered exogenously in a sample collected on 27 January 2019 during the Telenet UCI Cyclo-cross World Cup in Hoogerheide, Netherlands.

This doping control was planned and carried out by the Cycling Anti-Doping Foundation (CADF), the independent body mandated by the UCI, in charge of defining and implementing the anti-doping strategy in cycling.

The rider has the right to request and attend the analysis of her B sample.

In accordance with UCI Anti-Doping Rules, the rider has been provisionally suspended until the adjudication of the procedure.

At this stage of the procedure, the UCI will not comment any further on the matter.